Malaria Threat Resurfaces Due to Climate Change and Covid-19

The Asia Pacific Leaders Malaria Alliance (APLMA) and Asia Pacific Malaria Elimination Network (APMEN) welcomes the recently approved (14 March 2022) use of single-dose tafenoquine by the Australian Therapeutic Goods Administration (TGA) for the prevention of relapsing Plasmodium vivax (P. vivax) malaria in children aged 2 years and above.

APLMA is an affiliation of Asian and Pacific heads of government formed to accelerate progress against malaria and to eliminate it in the region by 2030.

APLMA is an affiliation of Asian and Pacific heads of government formed to accelerate progress against malaria and to eliminate it in the region by 2030.